Trial Outcomes & Findings for Acute Cardiovascular and Metabolic Effects of Exercise Training in Individuals With Insulin Resistance (NCT NCT00954109)
NCT ID: NCT00954109
Last Updated: 2015-04-06
Results Overview
Insulin sensitivity measured during an oral glucose tolerance test measured by the Matsuda Index. Matsuda insulin sensitivity index= 10000/square root of \[(fasting glucose × fasting insulin) × (mean glucose × mean insulin during oral glucose tolerance test).
COMPLETED
NA
11 participants
baseline and 24h after 5-7 days of exercise
2015-04-06
Participant Flow
Participant milestones
| Measure |
Exercise
exercise - supervised exercise (treadmill walking or cycle ergometer use)
Exercise: daily exercise: supervised treadmill walking or cycle ergometry use
|
|---|---|
|
Overall Study
STARTED
|
11
|
|
Overall Study
COMPLETED
|
11
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Acute Cardiovascular and Metabolic Effects of Exercise Training in Individuals With Insulin Resistance
Baseline characteristics by cohort
| Measure |
Arm 1
n=11 Participants
exercise - supervised exercise (treadmill walking or cycle ergometer use)
Exercise: daily exercise: supervised treadmill walking or cycle ergometry use
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=93 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
11 Participants
n=93 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=93 Participants
|
|
Age, Continuous
|
53 years
STANDARD_DEVIATION 2 • n=93 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=93 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=93 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=93 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=93 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=93 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=93 Participants
|
|
Race (NIH/OMB)
White
|
10 Participants
n=93 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=93 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=93 Participants
|
|
Region of Enrollment
United States
|
11 participants
n=93 Participants
|
PRIMARY outcome
Timeframe: baseline and 24h after 5-7 days of exerciseInsulin sensitivity measured during an oral glucose tolerance test measured by the Matsuda Index. Matsuda insulin sensitivity index= 10000/square root of \[(fasting glucose × fasting insulin) × (mean glucose × mean insulin during oral glucose tolerance test).
Outcome measures
| Measure |
Arm 1
n=11 Participants
exercise - supervised exercise (treadmill walking or cycle ergometer use)
Exercise: daily exercise: supervised treadmill walking or cycle ergometry use
|
|---|---|
|
Insulin Sensitivity After 5-7 Days of Exercise
Baseline
|
3 index score
Standard Error .2
|
|
Insulin Sensitivity After 5-7 Days of Exercise
Post 5-7 days of exercise
|
2.5 index score
Standard Error 0.3
|
PRIMARY outcome
Timeframe: pre and 24 hours post 5-7 days of exerciseBlood flow response in the femoral artery measured by Doppler ultrasound during and oral glucose tolerance test. Data are represented as % change in blood flow during the oral glucose tolerance at 60 minutes vs. 0 minutes (prior to drinking the glucose)
Outcome measures
| Measure |
Arm 1
n=11 Participants
exercise - supervised exercise (treadmill walking or cycle ergometer use)
Exercise: daily exercise: supervised treadmill walking or cycle ergometry use
|
|---|---|
|
Blood Flow in Response to Oral Glucose Tolerance Tests
Post 5-7 days of exercise
|
40 percentage change
Standard Error 20
|
|
Blood Flow in Response to Oral Glucose Tolerance Tests
Baseline
|
0 percentage change
Standard Error 2
|
Adverse Events
Arm 1
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
John Thyfault, Associate Professor
Harry S Truman Memorial VA Hospital and University of Missouri
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place